NVIDIA Endeavor - NVIDIA's Endeavor building in Santa Clara, California. | Photo courtesy of NVIDIAOath Surgical is deepening its bet on artificial intelligence in outpatient surgery through a new collaboration with NVIDIA (Nasdaq: NVDA).
The move further positions the up-and-coming company as one of the more aggressive experiments in building AI-native ambulatory surgery centers (ASCs) from the ground up. NVIDIA is the well-known technology company that makes powerful computer chips and software used for artificial intelligence, data centers and other advanced computing applications.
Specifically, the San Francisco-based Oath Surgical on Jan. 27 announced it will work with NVIDIA to power OathOS, its multimodal, ambient clinical intelligence platform, with advanced AI infrastructure capable of analyzing surgical video, audio and operational data in real time.
The partnership is aimed at supporting what Oath describes as the next generation of value-based, outpatient surgery, spanning the full episode of care from referral through recovery.
The announcement underscores a broader push by Oath to differentiate itself not just as an ASC operator, but as a vertically integrated technology and care delivery platform. While many health systems and ASC operators are experimenting with point-solution AI tools, Oath’s model centers on owning and operating its facilities while embedding AI into both the physical and digital infrastructure of surgery.
“Surgery is entering an AI era, but it only works if the underlying systems are rebuilt so clinical knowledge and data can be analyzed and learned from, at scale,” Oliver Keown, founder and CEO of Oath Surgical, said in a press release. “Our full-stack platform combines the data, the facilities, and the workflows where care actually happens.”
Founded with the premise that surgery is one of health care’s most data-rich yet underutilized environments, Oath has built what it calls AI-native surgical centers, or facilities designed specifically to capture, analyze and learn from clinical and operational signals in real time.
The company owns and operates three outpatient surgical centers in the Portland, Oregon, market. Keown told ASC News in an email that additional centers in new markets are slated to open in 2026.
Oath’s approach has drawn attention from both investors and industry observers.
The company has raised $35 million in total funding from backers including FPV Ventures and McKesson Ventures. In late 2025, Oath closed a $24 million round to expand its surgeon-led ASC footprint and continue development of its AI platform.
The collaboration with NVIDIA is not a simple licensing arrangement, Keown told ASC News, but rather “a multi-phased, strategic collaboration” that’s focused on building foundational infrastructure for multimodal clinical intelligence.
NVIDIA’s spatial AI capabilities will support real-time video and audio analysis in the operating room, enabling what Oath describes as agentic workflows that automate documentation, surface insights during procedures and reduce administrative burden for surgeons.
Keown shared several examples of how the NVIDIA partnership and OathOS could benefit ASC operations.
During procedures, OathOS analyzes surgical video, audio and patient context in real time. When a case is completed, surgeons are presented with a detailed, auditable operative note to review and approve, rather than documenting from memory after the fact. By capturing exactly what occurred – including procedures performed, devices used and clinical complexity – the platform is intended to support more accurate coding and billing at the time of surgery, reducing rework and revenue cycle delays.
Beyond documentation and billing, OathOS can aggregate intraoperative data and link it with longitudinal patient outcomes, creating what the company describes as a first-of-its-kind quality registry for outpatient surgery. Over time, those datasets could be used to benchmark performance, refine workflows and support value-based care models.
NVIDIA’s infrastructure will also help unify data across the perioperative continuum, connecting operating room activity with referral management, scheduling, outcomes measurement and patient engagement.
The partnership comes as interest in AI-enabled surgery accelerates across the ASC sector, driven by workforce pressures, reimbursement scrutiny and growing demand for outpatient procedures.
In addition to the three ASCs it owns and operates directly, Oath partners with more than 175 surgeons and 20 affiliated ASCs through its nationwide network, according to the company.
“Oath’s thesis is that most higher-acuity procedures can be safely and effectively delivered in ASCs, if the right clinical standards, vetted surgeons, technology, and data and analytics are in place,” Keown previously told ASC News. “That’s what Oath is building. We’re not just layering software on top of the old system; we’re creating a new one that supports the safe delivery of complex surgery outside the hospital.”
